Clinical NGS Assays: Exploring Technical Mechanism and Clinical Utility
August 18-19, 2015 | Capital Hilton Hotel, Washington, DC
With more clinical labs consistently turning to next-generation sequencing (NGS) assays, there is an overwhelming need to understand the fundamentals of running, designing, analyzing and validating NGS tests. CHI’s Second Annual Clinical NGS Assays will provide attendees with a comprehensive view of the technical considerations for implementing NGS assays as well as showcase best practices. Regulatory issues specific to NGS such as CLIA accreditation and FDA clearance will also be addressed from both the academic lab and commercial lab perspective. Finally, the clinical potential for NGS technologies will be explored by both physicians and research scientists, providing future directions for successful implementation. This conference is part of CHI’s Seventh Annual Next Generation Dx Summit.
August 18-19, 2015 | Capital Hilton Hotel, Washington, DC
With more clinical labs consistently turning to next-generation sequencing (NGS) assays, there is an overwhelming need to understand the fundamentals of running, designing, analyzing and validating NGS tests. CHI’s Second Annual Clinical NGS Assays will provide attendees with a comprehensive view of the technical considerations for implementing NGS assays as well as showcase best practices. Regulatory issues specific to NGS such as CLIA accreditation and FDA clearance will also be addressed from both the academic lab and commercial lab perspective. Finally, the clinical potential for NGS technologies will be explored by both physicians and research scientists, providing future directions for successful implementation. This conference is part of CHI’s Seventh Annual Next Generation Dx Summit.